NCT07045194View on ClinicalTrials.gov

Virtue® SAB in the Treatment of Coronary ISR Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

740

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

October 31, 2032

Conditions
Coronary Artery Disease
Interventions
DEVICE

Virtue Sirolimus AngioInfusion Balloon

Percutaneous Coronary Intervention

DEVICE

AGENT™ Paclitaxel Drug-Coated Balloon

Percutaneous Coronary Intervention

Sponsors
All Listed Sponsors
lead

Orchestra BioMed, Inc

INDUSTRY

NCT07045194 - Virtue® SAB in the Treatment of Coronary ISR Trial | Biotech Hunter | Biotech Hunter